KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 123 filers reported holding KALA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $99,000 | -26.1% | 447,683 | 0.0% | 0.00% | – |
| Q2 2022 | $134,000 | -89.8% | 447,683 | -53.1% | 0.00% | – |
| Q1 2022 | $1,317,000 | +33.7% | 954,773 | +17.2% | 0.00% | – |
| Q4 2021 | $985,000 | -59.7% | 814,734 | -12.7% | 0.00% | – |
| Q3 2021 | $2,445,000 | -38.8% | 933,242 | +23.9% | 0.00% | -100.0% |
| Q2 2021 | $3,992,000 | -13.2% | 753,298 | +10.4% | 0.00% | 0.0% |
| Q1 2021 | $4,599,000 | +12.7% | 682,489 | +13.4% | 0.00% | 0.0% |
| Q4 2020 | $4,079,000 | -6.7% | 601,728 | +3.2% | 0.00% | 0.0% |
| Q3 2020 | $4,372,000 | -33.9% | 583,057 | -7.4% | 0.00% | 0.0% |
| Q2 2020 | $6,617,000 | +118.4% | 629,665 | +82.7% | 0.00% | 0.0% |
| Q1 2020 | $3,030,000 | +21.7% | 344,731 | -48.9% | 0.00% | – |
| Q4 2019 | $2,490,000 | +113.9% | 674,824 | +120.6% | 0.00% | – |
| Q3 2019 | $1,164,000 | -40.2% | 305,936 | +0.3% | 0.00% | – |
| Q2 2019 | $1,945,000 | -8.5% | 304,886 | +18.6% | 0.00% | -100.0% |
| Q1 2019 | $2,126,000 | +8.8% | 257,086 | -35.7% | 0.00% | – |
| Q4 2018 | $1,954,000 | +77.6% | 399,870 | +258.8% | 0.00% | – |
| Q3 2018 | $1,100,000 | -13.1% | 111,451 | +20.8% | 0.00% | – |
| Q2 2018 | $1,266,000 | -5.2% | 92,270 | +9.3% | 0.00% | – |
| Q1 2018 | $1,336,000 | +4.8% | 84,428 | +22.4% | 0.00% | – |
| Q4 2017 | $1,275,000 | -15.0% | 68,987 | +5.0% | 0.00% | -100.0% |
| Q3 2017 | $1,500,000 | – | 65,689 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,142,360 | $7,745,000 | 4.83% |
| RA Capital Management | 10,874,613 | $73,730,000 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 43,431 | $294,462,000 | 0.93% |
| Parkman Healthcare Partners LLC | 272,445 | $1,847,000 | 0.47% |
| Samsara BioCapital, LLC | 601,162 | $4,076,000 | 0.41% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $693,000 | 0.40% |
| Eventide Asset Management | 3,450,000 | $23,391,000 | 0.36% |
| Orbimed Advisors | 5,465,030 | $37,053,000 | 0.32% |
| Vivo Capital, LLC | 786,883 | $5,335,000 | 0.24% |
| Knights of Columbus Asset Advisors LLC | 169,429 | $1,149,000 | 0.12% |